Vaxart Announces Retirement of Chairman Michael J. Finney, Ph.D.
1. Vaxart's Chairman, Michael J. Finney, announces retirement effective September 30, 2025. 2. Finney expressed pride in Vaxart's accomplishments and confidence in its future. 3. The Board will evaluate leadership and composition this month based on stockholder feedback. 4. Vaxart is developing oral vaccines, positioning itself for diverse vaccine markets. 5. Vaxart's innovative pill delivery system eliminates needle injury risks and aids storage.